Christina Ohnsman

Christina Ohnsman


Job title: Senior Clinical Development Lead


Christina Ohnsman, MD is Senior Clinical Development Lead of gene therapy for rare diseases at REGENXBIO Inc. Prior to this, she provided strategic guidance to Spark Therapeutics during the development and launch of Luxturna®. A pediatric ophthalmologist by background and founder of a medical communications and consulting firm, her passion is bringing gene therapies to people living with rare, previously untreatable diseases.

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.